Related Experiment Video
Updated: Aug 13, 2026
14:57
Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Tumor suppression and normal aging in mice with constitutively high p53 activity
Susan M Mendrysa1, Kathleen A O'Leary, Matthew K McElwee
1Department of Oncology, University of Wisconsin, Madison, 53706, USA.
Genes & Development
|January 5, 2006
Summary
Targeting the p53 inhibitor murine double-minute gene 2 (Mdm2) shows promise for cancer therapy. Reduced Mdm2 levels inhibited tumor formation in mice without causing premature aging, suggesting a safe therapeutic window.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The p53 inhibitor, murine double-minute gene 2 (Mdm2), is a key regulator of the tumor suppressor p53.
- Mdm2 inhibition is a potential cancer therapeutic strategy, but concerns exist regarding toxicity due to elevated p53 activity.
- Understanding the precise impact of reduced Mdm2 function on tumorigenesis and organismal health is crucial.
Purpose of the Study:
- To investigate whether decreased Mdm2 function can inhibit tumor development without inducing lethal side effects.
- To evaluate the consequences of reduced Mdm2 levels and consequently increased p53 activity on cancer incidence and lifespan in a murine model.
Main Methods:
- Utilized a hypomorphic murine allele of mdm2 to create mice with decreased Mdm2 levels.
- Compared tumor formation rates and lifespan between mice with reduced Mdm2 function and control groups.
- Assessed the impact of modulated Mdm2/p53 activity on tumorigenesis and aging phenotypes.
Main Results:
- Mice with decreased Mdm2 levels exhibited significant resistance to tumor formation.
- These mice did not display signs of premature aging or shortened lifespan.
- The findings demonstrate a therapeutic window for Mdm2 inhibition in cancer treatment.
Conclusions:
- Reduced Mdm2 function effectively suppresses tumorigenesis.
- Targeting Mdm2 offers a promising therapeutic strategy for cancer, as it can inhibit tumor growth without causing detrimental aging-related side effects.
- Mdm2 is a viable target for developing novel cancer therapeutics.
Related Concept Videos
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
01:12Loss of Tumor Suppressor Gene Functions
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
02:15Replicative Cell Senescence
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
02:43Mouse Models of Cancer Study
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...